Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 63
Filtrar
1.
Zhonghua Yan Ke Za Zhi ; 59(10): 824-831, 2023 Oct 11.
Artículo en Chino | MEDLINE | ID: mdl-37805416

RESUMEN

Objective: To investigate the long-term outcomes of corneal grafts after penetrating keratoplasty(PK) for congenital corneal opacity(CCO) in children aged 0 to 5 years and the related influencing factors. Methods: It was a retrospective series case study. Data of 39 children (55 eyes) who underwent PK surgery due to CCO in the keratology Department of Beijing Tongren Hospital from April 2014 to April 2018 and were followed up for more than 30 months were collected. Among them, there were 17 males (43.6%) and 22 females (56.4%). The age at operation was (16.2±13.3) months, and the follow-up time was (46.4±13.8) months. Clinical data such as basic information, preoperative diagnosis, operation age, operation method and postoperative complications were recorded. The corneal graft transparency was analyzed according to preoperative diagnosis, corneal neovascularization area, age at surgery, monocular or binocular surgery interval, primary surgery type and further surgery, and postoperative complications were observed. Results: At 12 months, 24 months and the last follow-up after PK, 78.2% (43/55), 70.9% (39/55) and 58.2% (32/55) of the affected eyes had clear corneal grafts, respectively.There was no statistical significance between Peters anomaly and sclerocornea (P>0.05), while the extent of neovascularization in the limbus had a significant effect on corneal graft transparency, and graft opacity was more likely to occur in patients with vessel area exceeding 2 quadrants (P<0.05).The highest corneal graft transparency was found in children aged 1 to 3 years 80.8%(21/26) (P<0.05), followed by children younger than 6 months (7/15).The translucency rate of the corneal graft was higher in patients undergoing unilateral surgery than in those undergoing bilateral surgery (P<0.05).Translucency of corneal graft was higher in children with simple surgery than with combined surgery (P<0.05), however, cataract surgery after PK had no significant effect on corneal graft transparency (P>0.05).The postoperative complications mainly included immune rejection in 19 eyes (34.5%), complicated cataract in 13 eyes (23.6%), glaucoma in 7 eyes (13.2%), persistent corneal epithelial defect in 7 eyes (13.2%). Conclusions: After PK in children with CCO, the transparent rate of corneal grafts decreases gradually with time, but the long-term translucency of corneal grafts can still be obtained. The range of corneal neovascularization, age at the time of surgery, whether the surgery was binocular and whether the surgery was combined had an effect on the transparency of corneal graft.


Asunto(s)
Catarata , Neovascularización de la Córnea , Opacidad de la Córnea , Niño , Masculino , Femenino , Humanos , Queratoplastia Penetrante/efectos adversos , Estudios Retrospectivos , Opacidad de la Córnea/cirugía , Complicaciones Posoperatorias/cirugía , Catarata/complicaciones , Supervivencia de Injerto , Estudios de Seguimiento , Resultado del Tratamiento
2.
Zhonghua Yan Ke Za Zhi ; 59(6): 481-483, 2023 Jun 11.
Artículo en Chino | MEDLINE | ID: mdl-37264579

RESUMEN

A 50-year-old female patient presented to the Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, with complaints of right eye pain, tearing, and difficulty opening the eye for over a month after intrastromal corneal ring segment (ICRS) implantation 18 years prior in both eyes. Slit lamp examination revealed corneal stromal melting around the ICRS at the 3 to 4 o'clock position of the right eye, with fluorescein staining. Optical coherence tomography showed epithelial and superficial stromal layer defects in the area of the lesion. The patient was diagnosed with corneal melting after ICRS implantation in the right eye. Under general anesthesia, the corneal stromal ring was removed, and deep lamellar keratoplasty was performed. The patient had no discomfort and the corneal graft remained transparent after the surgery.


Asunto(s)
Trasplante de Córnea , Queratocono , Femenino , Humanos , Persona de Mediana Edad , Implantación de Prótesis , Sustancia Propia/cirugía , Prótesis e Implantes/efectos adversos , Tomografía de Coherencia Óptica , Trasplante de Córnea/efectos adversos , Topografía de la Córnea , Queratocono/cirugía
3.
Zhonghua Yan Ke Za Zhi ; 58(6): 426-432, 2022 Jun 11.
Artículo en Chino | MEDLINE | ID: mdl-35692024

RESUMEN

Objective: To investigate the corneal graft survival and related risk factors of primary penetrating keratoplasty in congenital corneal opacity infants. Methods: It was a retrospective cohort study. Data were collected from forty-two infants (51 eyes) who were aged ≤12 months and diagnosed with congenital corneal opacity in Beijing Tongren Hospital and Beijing Anzhen Hospital from January 1, 2017 to January 31, 2018. The mean age at surgery was (5.7±2.2) months (3-12 months). The mean follow-up duration was (28.6±2.6) months (24-33 months). All the patients underwent penetrating keratoplasty. The status of the corneal grafts and complications were observed and recorded during the regular follow-up. The survival probabilities were estimated by using the Kaplan-Meier and Log-rank test. The graft survival between different influence factors was analyzed by using the χ2 test. Results: The Kaplan-Meier survival rates for penetrating keratoplasty were 84.3% (43/51) at 6 months, 78.4% (40/51) at 12 months and 60.8% (31/51) at the last follow-up. The presence of corneal neovascularization was significantly correlated with graft failure (χ²=5.264, P=0.022). The graft survival differed between eyes receiving combined surgery and mere penetrating keratoplasty and in eyes with varied surgical indications (P=0.039, <0.01). Increased intraocular pressure (7 eyes, 13.7%) and persistent epithelial defects (7 eyes, 13.7%) were the most common postoperative complications, followed by complicated cataract (4 eyes, 7.8%) and posterior capsule opacification (2 eyes, 3.9%). Conclusions: The graft survival rate was satisfactory following pediatric keratoplasty although it had a tendency to decrease with the follow-up time. Corneal neovascularization was a major risk factor of graft failure. Surgical indications and procedures also had a certain effect on the graft survival.


Asunto(s)
Enfermedades de la Córnea , Neovascularización de la Córnea , Opacidad de la Córnea , Anomalías del Ojo , Niño , Enfermedades de la Córnea/complicaciones , Enfermedades de la Córnea/cirugía , Neovascularización de la Córnea/complicaciones , Neovascularización de la Córnea/cirugía , Opacidad de la Córnea/cirugía , Anomalías del Ojo/cirugía , Estudios de Seguimiento , Supervivencia de Injerto , Humanos , Lactante , Queratoplastia Penetrante/efectos adversos , Queratoplastia Penetrante/métodos , Estudios Retrospectivos , Resultado del Tratamiento
4.
Zhonghua Yan Ke Za Zhi ; 57(8): 561-563, 2021 Aug 11.
Artículo en Chino | MEDLINE | ID: mdl-34344115

RESUMEN

Drug-induced ocular surface injury often occurs in the clinical diagnosis and treatment of eye diseases. Because of concealed clinical manifestations, it is difficult to be distinguished, causing misdiagnosis and mistreatment, and leading to serious corneal and conjunctival damage, and even visual disfunction. In this article, we focus on the mechanism, active prevention and effective treatment of drug-induced ocular surface injury, and propose that the rational use of local eye drugs can effectively reduce or avoid drug-induced ocular surface injury and improve the clinical diagnosis and treatment of eye diseases. (Chin J Ophthalmol, 2021, 57: 561-563).


Asunto(s)
Lesiones Oculares , Preparaciones Farmacéuticas , Conjuntiva , Córnea , Lesiones Oculares/inducido químicamente , Humanos
5.
Zhonghua Yan Ke Za Zhi ; 56(10): 768-773, 2020 Oct 11.
Artículo en Chino | MEDLINE | ID: mdl-33059420

RESUMEN

Objective: To observe the clinical effect of modified conjunctival transplantation and amniotic membrane transplantation combined with use of interferon (IFN) alpha-2b eye drops in the treatment of primary pterygium. Methods: This was a prospective case-control study. Patients with primary pterygium were treated from June 1, 2018 to December 31, 2018 in the Department of Ophthalmology, Beijing Tongren Hospital, and they were divided into two groups (the experimental group and the control group) by the method of randomized block design. Patients in the experimental group received modified conjunctival transplantation and amniotic membrane transplantation combined with use of IFN alpha-2b eye drops, while patients in the control group received pterygium resection combined with conjunctival autograft transplantation. The pterygium type and size were observed before operation, while visual acuity, intraocular pressure and anterior segment details were recorded either. The follow-up was done at 1 week, 2 weeks, 1 month, 3 months, 6 months and 12 months after operation. The visual acuity, corneal epithelial defect, and pterygium recurrence were observed. All data in this manuscript are enumeration data, the expected frequency of pterygium type distribution in the two groups was more than 5, and the chi square test was used, fisher's exact test was used to compare the other data between the two groups. Results: Seventy patients (77 eyes) with pterygium were in this study, including 30 males and 40 females, aged from 50-70 years old. There were 35 cases (38 eyes) in the experimental group and 35 cases (39 eyes) in the control group. 12 months after operation there were 54 cases (60 eyes) including 28 cases (30 eyes) in the experimental group and 26 cases (30 eyes) in the control group with complete data. The corneal epithelium defects of 1 eye in each group was repaired within 7-14 days after operation, and the rest eyes were completely repaired within 7 days after operation. There was no significant difference in the distribution of corneal epithelial healing between the two groups (P= 1.00). There was no significant difference between the two groups in the number of eyes distribute with decreased visual acuity (2 eyes in each group), stable visual acuity (15 eyes in the experimental group and 23 eyes in the control group), and improved visual acuity (13 eyes in the experimental group and 5 eyes in the control group) (P=0.053). There was no recurrence in the two groups at 12 months after surgery, and there was no significant difference between the two groups in the number of patients with conjunctival hyperplasia of grades 1, 2 and 3 (P=0.405). Conclusions: Modified conjunctival transplantation and amniotic membrane transplantation combined with use of IFN alpha-2b eye drops got low recurrence rate for primary pterygium and less damage to the healthy conjunctival tissue. This combined treatment strategy provides a new choice for the treatment of pterygium. (Chin J Ophthalmol, 2020, 56: 768-773).


Asunto(s)
Amnios , Interferón alfa-2 , Pterigion , Anciano , Amnios/trasplante , Estudios de Casos y Controles , Femenino , Humanos , Interferón alfa-2/uso terapéutico , Interferones , Masculino , Persona de Mediana Edad , Soluciones Oftálmicas , Estudios Prospectivos , Pterigion/tratamiento farmacológico , Pterigion/cirugía
6.
Zhonghua Yan Ke Za Zhi ; 55(12): 923-927, 2019 Dec 11.
Artículo en Chino | MEDLINE | ID: mdl-31874506

RESUMEN

Objective: To discuss effect of autologous simple limbal epithelial transplantation (SLET) performed for unilateral limbal stem cell deficiency (LSCD). Methods: Retrospective case study. In this retrospective study, records of 7 patients (7 eyes) who had undergone autologous SLET for unilateral LSCD, with a minimum of 6 months of follow-up, were reviewed. Demographic details, etiology of LSCD, duration between ocular burn and SLET, prior surgery performed, presence or absence of symblepharon, pre-and post-operative visual acuity, and complications were noted. Results: Seven eyes of 7 patients underwent autologous SLET. With a follow-up of 6 months, a completely epithelialised and stable corneal surface was obtained in all recipient eyes. Visual acuity improved in all patients, while none of the eyes developed any complications. Conclusions: Autologous SLET is an effective and safe modality for treatment of unilateral LSCD. Clinical success rates and visual acuity improvement are equal to or better than those reported with earlier techniques. (Chin J Ophthalmol, 2019, 55:923-927).


Asunto(s)
Quemaduras Químicas , Enfermedades de la Córnea , Epitelio Corneal , Limbo de la Córnea , Enfermedades de la Córnea/terapia , Epitelio Corneal/trasplante , Humanos , Limbo de la Córnea/citología , Estudios Retrospectivos , Trasplante de Células Madre , Trasplante Autólogo
7.
Zhonghua Yan Ke Za Zhi ; 55(6): 419-427, 2019 Jun 11.
Artículo en Chino | MEDLINE | ID: mdl-31189271

RESUMEN

Objective: To observe the effectiveness and safety of topical 0.1% tacrolimus(FK506) as immunosuppressant in high-risk penetrating corneal transplantation to prevent the immune rejection and to compare the outcomes with topical 1% Cyclosporin A (CsA). Methods: The study consists of 49 patients (50 eyes), who were fitted with the high-risk corneal transplantation standard and undergone the penetrating keratoplasty(PKP) or combined operation in Beijing Tongren hospital between March 2015 to September. With the time sequence, the patients were divided into observation group (FK506 group) and the control group (CsA group). The observation group included 9 females and 16 males with an average age of 57.8±14.8. Twenty-four patients were in the control group (25 eyes), including 10 females and 14 males, with an average age of (45.1±16.2). Observation group was treated with topical 0.1% tacrolimus, and the control group treated with topical 1%CsA. Both groups' treatment combined glucocorticoid as well. Two groups had 1 year follow-up observation. The incidence of rejection was compared by statistical methods of Cox regression. The adverse reactions were graded and compared using Mann-Whitney U test. Results: After one year, 22 cases of the observation group and 23 cases of the control group were accomplished all observations. The rejection rate was 4.54% in observation group and 27.23% in control group. The difference between the groups was statistically significant (χ(2)=4.291, P=0.038). Control group had high rejection rate. Besides, there was no severe side effects happened in both groups. After 1 month after surgery, 36.4% of the observation group showed mild corneal edema. The ratio of mild to moderate corneal edema in the control group was 26.1% and 8.7%. Three months after surgery, 4.5% of the observation group showed mild corneal edema, while 13.0% and 13.0% of the control group was found mild to moderate corneal edema. Six months after surgery, 4.5% of the observation group showed moderate corneal edema. The ratio of mild, moderate to severe corneal edema in the control group was 17.4%, 17.4% and 8.7%. The degree of corneal edema in the control group was more serious in three monthes(Z=-2.770, -2.018, -2.941, P<0.05). The differences in both monthes were statistically significant. Mild neovascularization occurred in the 13.6% of observation group. Mild to severe neovascularization occurred in the 13.0%, 4.3%, and 4.3% control groups. The degree of neovascularization in the control group was higher than that in the observation group(Z=-3.221, P=0.001). The differences in both months were statistically significant. Mild to moderate neovascularization occurred in the 18.2% and 9.1% of observation group. Mild to extremely severe neovascularization occurred in the 17.4%, 26.1%, 4.3% and 4.3% control groups. The degree of neovascularization in the control group was higher than that in the observation group(Z=-1.988, P=0.047).The differences in both monthes were statistically significant. Conclusions: Both 0.1% tacrolimus and 1% cyclosporine A are safe and effective in reducing the rejection after high-risk corneal transplantation. (Chin J Ophthalmol, 2019, 55: 419-427).


Asunto(s)
Inmunosupresores , Queratoplastia Penetrante , Tacrolimus , Adulto , Anciano , Ciclosporina , Femenino , Rechazo de Injerto , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Tacrolimus/uso terapéutico
8.
Transplant Proc ; 49(8): 1712-1718, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28923613

RESUMEN

BACKGROUND: Lack of willingness to pledge eyes among the general population is the main cause for the shortage of cornea tissue in China. A few studies have implied that general-population adults with specific demographics showed more willingness to donate their eyes. METHODS: In this study, we analyzed the demographic characteristics of 918 voluntary donors registered in Beijing Tongren Hospital Eye Bank in the past 10 years for possible predictors that might help us to identify potential donors in Beijing and increase the donation rate. All copies of voluntary eye donation application forms filled by the registrants from 2007 to 2016 were collected. Basic demographics listed in the application form were extracted for analysis. Demographics were described as proportions and compared by means of a χ2 test. Besides that, donor counts and proportions of combining 2 demographics from the 4 main demographics were described and compared. RESULTS: Voluntary donors greater than 50 years of age (n = 477, 53.0%) predominated the proportions. Regarding education level and occupation, donors with tertiary education (n = 484, 57.4%) were more numerous than donors with primary and secondary education (n = 355, 42.1%); office clerks, workers, and government officers were more willing to pledge eyes than were donors engaged in other occupations. In addition, donors of the Han race (n = 856, 94.9%) made up the majority and mainly were distributed in 5 central administrative districts of Beijing (n = 629, 77.5%). CONCLUSIONS: The present study suggests that older women (>50 years of age), living in a central district, with higher education level and engaged in white-collar work, were possible predictors for potential donors.


Asunto(s)
Bancos de Ojos , Donantes de Tejidos/estadística & datos numéricos , Obtención de Tejidos y Órganos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , China , Trasplante de Córnea , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Donantes de Tejidos/provisión & distribución , Obtención de Tejidos y Órganos/métodos , Obtención de Tejidos y Órganos/estadística & datos numéricos , Voluntarios , Adulto Joven
9.
Zhonghua Yi Xue Za Zhi ; 97(24): 1883-1887, 2017 Jun 27.
Artículo en Chino | MEDLINE | ID: mdl-28648014

RESUMEN

Objective: To investigate the clinical efficacy of atomization inhalation combined with oral administration of oseltamivir in treatment of human infection with H7N9 avian influenza. Methods: To analyze the clinical data of 4 patients hospitalized from Mar 6th 2017 to Apr 12th 2017 with avian influenza(H7N9) infection treated by conventional therapy(oseltamivir, 150 mg, po, Bid) plus with oseltamivir inhalation(75 mg dissolved in 20 ml N. S, Bid) and administered with antibacterial treatment, blood purification and immunomodulators. Results: Undergoing these comprehensive therapies, Bronchial lavage fluid and pharynx of 1 case was negative for H7N9 RNA after 24 h, 2 cases negative for H7N9 after 3 d and 1 case negative for H7N9 RNA after 4 d. All patients were cured and discharged without any complications. Conclusions: Aseltamivir inhalation combined with oral treatment can significantly shorten the time of virus nucleic acid turning negative, improve the efficacy of anti avian influenza virus H7N9, and increase the cure rate of avian influenza H7N9 infection patients.


Asunto(s)
Antivirales/administración & dosificación , Subtipo H7N9 del Virus de la Influenza A , Gripe Humana/tratamiento farmacológico , Oseltamivir/administración & dosificación , Administración por Inhalación , Administración Oral , China , Humanos , Resultado del Tratamiento
10.
Zhonghua Yan Ke Za Zhi ; 52(9): 641-3, 2016 Sep 11.
Artículo en Chino | MEDLINE | ID: mdl-27647243

RESUMEN

Corneal transplantation is an important method in the treatment of corneal blindness. It is imperative to improve the treatment effectiveness of corneal disease and reduce the possibility of corneal blindness with the progress of corneal transplantation surgery, the construction and development of eye banks and the rational use of donor materials. This article reviews the component corneal transplantation technology promotion, eye bank construction and preparation of donor slices for component corneal transplantation surgery. (Chin J Ophthalmol, 2016, 52: 641-643).


Asunto(s)
Ceguera/cirugía , Córnea , Trasplante de Córnea/métodos , Bancos de Ojos/organización & administración , Enfermedades de la Córnea/cirugía , Humanos , Donantes de Tejidos , Resultado del Tratamiento
11.
Zhonghua Yan Ke Za Zhi ; 52(3): 221-5, 2016 Mar.
Artículo en Chino | MEDLINE | ID: mdl-26979120

RESUMEN

The corneal allograft rejection is the primary reason for graft failure, but the existing agents are of limited efficacy and may be accompanied by unacceptable morbidity. Recently, antibody-based agents have received great attention and have become an important part of therapeutic intervention for organ transplantation, which is also a research focus in the field of corneal transplantation. This review summarizes the history, current situation and mechanism of antibody-based agents in corneal transplantation.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Enfermedades de la Córnea/tratamiento farmacológico , Trasplante de Córnea , Rechazo de Injerto/tratamiento farmacológico , Aloinjertos , Humanos , Trasplante Homólogo
12.
Ann Oncol ; 24(8): 2016-22, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23592700

RESUMEN

BACKGROUND: To investigate the role of Cullin1 (Cul1) in the development of breast cancer, we examined the expression of Cul1 in breast cancer tissues and analyzed the correlation between Cul1 expression and clinicopathologic variables and patients survival. PATIENTS AND METHODS: We evaluated the Cul1 expression by immunohistochemistry using a tissue microarray (TMA) which includes 393 breast cancer tissues. We also studied the role of Cul1 in breast cancer cell proliferation, migration and invasion by carrying out CCK8 cell proliferation assay, cell migration and invasion assay. RESULTS: The Cul1 expression was significantly correlated with breast cancer histology grade (P = 0.000), estrogen receptor status (P = 0.001), progesterone receptor status (P = 0.001) and human epidermal growth factor receptor 2 status (P = 0.002). Furthermore, we showed a strong correlation between high Cul1 expression and worse 5-year overall and disease-specific survival rates in breast cancer patients (P = 0.026 and P = 0.015, respectively). Finally, we found that Cul1 knockdown inhibits cell proliferation, migration and invasion abilities. CONCLUSIONS: Cul1 overexpression is significantly correlated with breast cancer progression and predicts worse survival. Cul1 regulates breast cancer cell proliferation, migration and invasion.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/mortalidad , Proteínas Cullin/metabolismo , Neoplasias de la Mama/patología , Línea Celular Tumoral , Movimiento Celular/genética , Proliferación Celular , Proteínas Cullin/biosíntesis , Proteínas Cullin/genética , Femenino , Humanos , Metaloproteinasa 2 de la Matriz/metabolismo , Persona de Mediana Edad , Invasividad Neoplásica/genética , Pronóstico , Interferencia de ARN , ARN Interferente Pequeño , Receptor ErbB-2/metabolismo , Receptores de Estrógenos/metabolismo , Receptores de Progesterona/metabolismo , Sobrevida , Análisis de Matrices Tisulares , Inhibidor Tisular de Metaloproteinasa-2/metabolismo
13.
Ir J Med Sci ; 182(4): 621-7, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23619562

RESUMEN

PURPOSE: The aim of this study was to determine the expression and function of miR-509-5p in renal cell carcinoma (RCC). MATERIALS AND METHODS: In this research, we have conducted quantitative real-time polymerase chain reaction (qRT-PCR) assay to determine the expression level of miR-509-5p in tissues and plasma from renal cell carcinoma patients. We preformed in vitro migration scratch assay, flow cytometry analysis and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to determine the exact function of miR-509-5p. RESULTS: We evaluated the expression level of miR-509-5p in RCC tissues and paired adjacent normal tissues from 42 patients and found that miR-509-5p expression in 42 RCC specimens was significantly down-regulated compared to that in adjacent normal tissue. Furthermore, the level of miR-509-5p in RCC patients' plasma was significantly lower than that in control plasma. In addition, the overexpression of miR-509-5p suppressed the proliferation of RCC cell (786-0), induced cell apoptosis and inhibited cell migration in vitro. CONCLUSION: In this study, we have shown that miR-509-5p played an important role in RCC by inhibiting cell proliferation and migration and by promoting cell apoptosis. In addition, miR-509-5p expression was significantly lower in RCC patient plasma compared to that in normal individuals.


Asunto(s)
Apoptosis , Biomarcadores de Tumor/metabolismo , Carcinoma de Células Renales/metabolismo , Movimiento Celular , Proliferación Celular , Neoplasias Renales/metabolismo , MicroARNs/metabolismo , Adolescente , Adulto , Biomarcadores de Tumor/sangre , Biomarcadores de Tumor/genética , Carcinoma de Células Renales/sangre , Carcinoma de Células Renales/genética , Línea Celular Tumoral , Niño , Preescolar , Regulación hacia Abajo , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Lactante , Neoplasias Renales/sangre , Neoplasias Renales/genética , Masculino , MicroARNs/sangre , MicroARNs/genética , Persona de Mediana Edad , Invasividad Neoplásica , Transfección , Adulto Joven
14.
Technol Cancer Res Treat ; 12(2): 99-107, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22974330

RESUMEN

The aim of this study is to evaluate the volume differences between contrast-enhanced CT-based left ventricle (LV) and PET-CT-based LV and assess the impact of dose on the substructure volume differences in patients with left breast cancer treated with adjuvant radiotherapy. From October 2008 to February 2009, 14 patients with post-operatively confirmed left breast cancer were enrolled in the current study. The patients were scanned using contrast-enhanced CT for simulation, and (18)F-FDG PET-CT was employed to display the structure of the left ventricle of each before radiotherapy (RT). The LV was delineated based on both contrast-enhanced CT and PET-CT. And other substructures, such as the left anterior descending coronary artery (LAD), were contoured in each patient, with the six-field simple intensity modulated radiotherapy (sIMRT) technique created for all. The mean volumes of the left ventricle based on contrast-enhanced CT (LV-CT) and PET-CT (LV-PET) were found to be 107.296 cm(3) and 112.931 cm(3), respectively (p = 0.06). The volume of LV receiving ≥ 50% prescription dose was significantly correlated with the volume of the heart receiving the same dosage (γ = 0.869). There was less correlation between the volume of LAD and that of the heart under the same condition (γ = 0.22). As a conclusion, the left ventricle can be delineated effectively based on the image of PET-CT, the contrast-enhanced CT based LV can serve as an appropriate alternative. Moreover, the volume of LV receiving high dose in RT closely correlated with the volume of the heart using sIMRT technique, which may pave the way for further exploring radiation-induced cardiac injuries in patients with left breast cancer.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Cardiopatías/diagnóstico por imagen , Ventrículos Cardíacos/diagnóstico por imagen , Traumatismos por Radiación/diagnóstico por imagen , Radioterapia de Intensidad Modulada/efectos adversos , Adulto , Anciano , Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/cirugía , Volumen Cardíaco/efectos de la radiación , Terapia Combinada , Femenino , Fluorodesoxiglucosa F18 , Cardiopatías/etiología , Ventrículos Cardíacos/fisiopatología , Ventrículos Cardíacos/efectos de la radiación , Humanos , Persona de Mediana Edad , Proyectos Piloto , Periodo Posoperatorio , Traumatismos por Radiación/etiología , Cintigrafía , Radiofármacos , Dosificación Radioterapéutica , Volumen Sistólico
15.
Eye (Lond) ; 23(1): 215-21, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18497832

RESUMEN

PURPOSE: To investigate whether glaucoma filtering surgery (GFS) in rats would impair the eye's capacity to induce anterior chamber-associated immune deviation (ACAID) and assess the possible mechanism involved. METHODS: Rats subjected to GFS were injected with bovine serum antigen (BSA) into the anterior chamber to induce ACAID. Animals that had their cervical lymph nodes (CLNs) excised before filtering surgery and those that had sham filtering surgery served as control comparison groups. Antigen-specific delayed-type hypersensitivity (DTH) was used to identify the induction of ACAID. Antigen level in the CLNs was indicated by the percentage of FITC-positive cells in CLNs after FITC dextran was injected into the anterior chamber. Statistical analyses were performed using the student's t-test for comparison of data between control and experimental groups. A P<0.05 was required for results to be considered statistically significant. RESULTS: Rats undergoing GFS demonstrated antigen-specific DTH, while those in the sham filtering surgery or CLNs excised groups failed to acquire an antigen-specific DTH response. The percentage of FITC-positive cells in CLNs was significantly increased (P=0.001) in GFS (mean+/-SD: 2.96+/-0.67%) vs controls (1.57+/-0.48%) at 1 day, but not at 3, 5, 7, or 12 days post-antigen injection. CONCLUSIONS: GFS prevents the induction of ACAID in rats, and the antigen drainage to CLNs plays a critical role in this process. The results suggest that the ocular immune status might be altered by GFS.


Asunto(s)
Cámara Anterior/inmunología , Cirugía Filtrante , Glaucoma/inmunología , Hipersensibilidad Tardía/inmunología , Análisis de Varianza , Animales , Antígenos , Dextranos/toxicidad , Drenaje , Femenino , Inmunidad Celular/inmunología , Escisión del Ganglio Linfático , Ratas , Ratas Sprague-Dawley , Albúmina Sérica Bovina/inmunología
16.
Ann ICRP ; 37(5): 1-105, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18555921

RESUMEN

In this report, the Commission recommends approaches to national authorities for their definition of the scope of radiological protection control measures through regulations, by using its principles of justification and optimisation. The report provides advice for deciding the radiation exposure situations that should be covered by the relevant regulations because their regulatory control can be justified, and, conversely, those that may be considered for exclusion from the regulations because their regulatory control is deemed to be unamenable and unjustified. It also provides advice on the situations resulting from regulated circumstances but which may be considered by regulators for exemption from complying with specific requirements because the application of these requirements is unwarranted and exemption is the optimum option. Thus, the report describes exclusion criteria for defining the scope of radiological protection regulations, exemption criteria for planned exposure situations, and the application of these concepts in emergency exposure situations and in existing exposure situations. The report also addresses specific exposure situations such as exposure to low-energy or low-intensity adventitious radiation, cosmic radiation, naturally occurring radioactive materials, radon, commodities, and low-level radioactive waste. The quantitative criteria in the report are intended only as generic suggestions to regulators for defining the regulatory scope, in the understanding that the definitive boundaries for establishing the situations that can be or need to be regulated will depend on national approaches.


Asunto(s)
Exposición a Riesgos Ambientales , Dosis de Radiación , Protección Radiológica/legislación & jurisprudencia , Urgencias Médicas , Humanos , Agencias Internacionales , Internacionalidad , Monitoreo de Radiación/legislación & jurisprudencia
17.
Science ; 294(5547): 1704-8, 2001 Nov 23.
Artículo en Inglés | MEDLINE | ID: mdl-11679633

RESUMEN

Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although many genes were up-regulated in a single rat model of atrophy, only a small subset was universal in all atrophy models. Two of these genes encode ubiquitin ligases: Muscle RING Finger 1 (MuRF1), and a gene we designate Muscle Atrophy F-box (MAFbx), the latter being a member of the SCF family of E3 ubiquitin ligases. Overexpression of MAFbx in myotubes produced atrophy, whereas mice deficient in either MAFbx or MuRF1 were found to be resistant to atrophy. These proteins are potential drug targets for the treatment of muscle atrophy.


Asunto(s)
Proteínas de Unión al ADN , Perfilación de la Expresión Génica , Músculo Esquelético/metabolismo , Atrofia Muscular/genética , Péptido Sintasas/metabolismo , Transactivadores , Secuencia de Aminoácidos , Animales , Clonación Molecular , Creatina Quinasa/genética , Forma MM de la Creatina-Quinasa , Eliminación de Gen , Suspensión Trasera , Humanos , Inmovilización , Isoenzimas/genética , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Desnervación Muscular , Proteínas Musculares/genética , Músculo Esquelético/crecimiento & desarrollo , Músculo Esquelético/patología , Músculo Esquelético/fisiopatología , Atrofia Muscular/patología , Atrofia Muscular/fisiopatología , Proteína MioD/genética , Factor 5 Regulador Miogénico , Miogenina/genética , Péptido Sintasas/química , Péptido Sintasas/deficiencia , Péptido Sintasas/genética , Fenotipo , Unión Proteica , ARN Mensajero/análisis , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Proteínas Ligasas SKP Cullina F-box , Regulación hacia Arriba
18.
J Mol Biol ; 312(4): 609-23, 2001 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-11575918

RESUMEN

The promyelocytic leukemia protein (PML) is a mammalian regulator of cell growth which is characteristically disrupted in acute promyelocytic leukemia and by a variety of viruses. PML contains a RING domain which is required for its growth-suppressive and antiviral properties. Although normally nuclear, in certain pathogenic conditions, including arenaviral infection, PML is relocated to the cytoplasm, where its functions are poorly understood. Here, we observe that PML and arenavirus protein Z use regions around the first zinc-binding site of their respective RING domains to directly interact, with sub-micromolar affinity, with the dorsal surface of translation initiation factor eIF4E, representing a novel mode of eIF4E recognition. PML and Z profoundly reduce the affinity of eIF4E for its substrate, the 5' 7-methyl guanosine cap of mRNA, by over 100-fold. Association with the dorsal surface of eIF4E and direct antagonism of mRNA cap binding by PML and Z lead to direct inhibition of translation. These activities of the RING domains of PML and Z do not involve ubiquitin-mediated protein degradation, in contrast to many RINGs which have been observed to do so. Although PML and Z have well characterized physiological functions in regulation of growth and apoptosis, this work establishes the first discrete biochemical mechanism which underlies the biological activities of their RING domains. Thus, we establish PML and Z as translational repressors, with potential contributions to the pathogenesis of acute promyelocytic leukemia and variety of viral infections.


Asunto(s)
Arenavirus/química , Proteínas de Neoplasias/química , Proteínas de Neoplasias/metabolismo , Proteínas Nucleares , Factores de Iniciación de Péptidos/antagonistas & inhibidores , Biosíntesis de Proteínas , Factores de Transcripción/química , Factores de Transcripción/metabolismo , Proteínas Virales/química , Proteínas Virales/metabolismo , Sitios de Unión , Dicroismo Circular , Factor 4E Eucariótico de Iniciación , Genes Reporteros , Células HeLa , Humanos , Ligasas/metabolismo , Modelos Moleculares , Mutación , Proteínas de Neoplasias/genética , Factores de Iniciación de Péptidos/metabolismo , Proteína de la Leucemia Promielocítica , Unión Proteica , Estructura Terciaria de Proteína , Caperuzas de ARN/biosíntesis , Caperuzas de ARN/metabolismo , Estabilidad del ARN , Espectrometría de Masa por Ionización de Electrospray , Termodinámica , Factores de Transcripción/genética , Proteínas Supresoras de Tumor , Ubiquitina-Proteína Ligasas , Ubiquitinas/metabolismo , Proteínas Virales/genética , Zinc/metabolismo
19.
Spectrochim Acta A Mol Biomol Spectrosc ; 56A(9): 1675-80, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10952129

RESUMEN

NMR analyses (TOCSY, HMQC and DOSY) indicate that, in the presence of water, acetonitrile is exclusively hydrolyzed to acetamide catalyzed by bisilver cryptate complex, which contains coordinating acetonitrile molecule.


Asunto(s)
Acetamidas/química , Acetonitrilos/química , Espectroscopía de Resonancia Magnética/métodos , Compuestos Organometálicos/química , Catálisis , Hidrólisis
20.
J Biol Chem ; 275(41): 32317-24, 2000 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-10921923

RESUMEN

The SCF-ROC1 ubiquitin-protein isopeptide ligase (E3) ubiquitin ligase complex targets the ubiquitination and subsequent degradation of protein substrates required for the regulation of cell cycle progression and signal transduction pathways. We have previously shown that ROC1-CUL1 is a core subassembly within the SCF-ROC1 complex, capable of supporting the polymerization of ubiquitin. This report describes that the CUL1 subunit of the bacterially expressed, unmodified ROC1-CUL1 complex is conjugated with Nedd8 at Lys-720 by HeLa cell extracts or by a purified Nedd8 conjugation system (consisting of APP-BP1/Uba3, Ubc12, and Nedd8). This covalent linkage of Nedd8 to CUL1 is both necessary and sufficient to markedly enhance the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization. A mutation of Lys-720 to arginine in CUL1 eliminates the Nedd8 modification, abolishes the activation of the ROC1-CUL1 ubiquitin ligase complex, and significantly reduces the ability of SCF(HOS/beta)(-TRCP)-ROC1 to support the ubiquitination of phosphorylated IkappaBalpha. Thus, although regulation of the SCF-ROC1 action has been previously shown to preside at the level of recognition of a phosphorylated substrate, we demonstrate that Nedd8 is a novel regulator of the efficiency of polyubiquitin chain synthesis and, hence, promotes rapid turnover of protein substrates.


Asunto(s)
Biopolímeros/metabolismo , Proteínas de Ciclo Celular/metabolismo , Proteínas Cullin , Proteínas I-kappa B , Ligasas/metabolismo , Complejos de Ubiquitina-Proteína Ligasa , Ubiquitinas/metabolismo , Sustitución de Aminoácidos , Ciclosoma-Complejo Promotor de la Anafase , Proteínas de Ciclo Celular/química , Proteínas de Ciclo Celular/genética , Proteínas de Unión al ADN/metabolismo , Activación Enzimática , Células HeLa , Humanos , Ligasas/genética , Lisina/química , Lisina/genética , Lisina/metabolismo , Sustancias Macromoleculares , Mutación/genética , Proteína NEDD8 , Inhibidor NF-kappaB alfa , Fosforilación , Poliubiquitina , Unión Proteica , Proteínas Recombinantes de Fusión/metabolismo , Ubiquitina-Proteína Ligasas , Ubiquitinas/química , Ubiquitinas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...